Precision Medicine

Study takes a comprehensive and data-driven look at what happens to the brain during and after concussion.

From establishing centralized support and building a clinical trial management system to improving data integration with its Epic EMR, the academic medical center has worked extensively to put the pieces in place for genomics.

This podcast explores one key question: Who owns/profits from the data? This is a key question today for electronic medical records, and a question that has no straight answer.

MIT-Harvard research center upgrades GATK technology, widens availability to speed precision medicine advances.

HIMSS, AHIMA, AMIA all say the drastic cuts to ONC and other agencies will hamper patient safety and new cures, send innovation in a downward spiral and slow down work toward a learning health system.

In this podcast, we will review some of the ideas we shared in our previous podcasts on this series. We will also provide insights into what is new, what is driving the most current state of change and what we see as the next potential drivers.

Today’s IT infrastructures are not hearty enough to support the data needs of genomics and other emerging healthcare practices and capabilities,  HIMSS Analytics says.

While healthcare is not applying the same kind of data understanding that other service rely on, precision medicine will bring that to the fore, expert says.

CRISPR has sparked considerable excitement for precision medicine, but patient safety, enzyme delivery and today’s level of disease understanding are limiting mainstream adoption.

An ambitious project aims to provide insight on “the most diverse collection of people in human history.”